en

PRODUCT DETAIL

Qarziba 4,5 mg/1 ml koncentrát na infúzny roztok

Code 3995C
MA number EU/1/17/1191/001
Product Form: con inf 1x4,5 ml/20 mg (liek.inj.skl.)
MA Status: Ev - Valid centralised marketing authorisation under exceptional circumstances
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FX Other monoclonal antibodies and antibody drug conjugates
L01FX06 Dinutuximab beta
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 08.05.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 18.05.2023
eu-flag.png sk-flag.png